Revolution Medicines deployed the DNAnexus Omics Data Catalog (ODC) to unify multimodal research assets & accelerate translational decision making. They centralized their multimodal datasets & achieve faster data discovery, improved collaboration, & maintain compliance.

Learn how Revolution Medicines accelerated their time‑to‑insight by making previously scattered multimodal datasets easy to discover and reuse. https://t.co/18AFWR0GQh #ODC #DataDiscovery #Multiomics #Genomics #Collaboration #TranslationalResearch

This webinar provides step-by-step instructions to achieve faster, de-risked hit-to-lead and build more predictive #AI models by collaborating in secure, governed joint workspaces. #Biomarkers #PopulationHealth #PrecisionMedicine

Now On Demand: accelerate your drug discovery pipelines with native access to the Tahoe-100M single-cell dataset on DNAnexus. Transform this population-scale single-cell dataset into precision health insights: https://t.co/2894VP4ybf #SingleCell #DrugDiscovery

@uk_biobank Jeff Keller, DNAnexus Executive VP & General Manager of Health Systems and Biobanks, joined a panel discussion on UKB-RAP that covered 2025 platform updates & the future roadmap which will add new agentic AI tools. Watch it now:

Thank you to our partners @uk_biobank for having us at their scientific conference! The conference was a valuable opportunity to connect with the UKB-RAP community & learn about their research that’s providing valuable healthcare insights. #UKBiobank #PopulationHealth

Our intuitive workflow builder enables centralized and scalable data management to drive faster time to discovery. Leverage JupyterLab notebooks and Panomics visualizations to perform comprehensive multi-omics analysis.

Translate complex omics data into powerful insights with the DNAnexus Platform. Request a demo today: https://t.co/5OWYwAzCat #JupyterLab #Panomics #Multiomics #Genomics #CloudPlatform

Learn how you can leverage the pre-loaded dataset on DNAnexus to facilitate secure collaboration with biotech partners. The Tahoe 100-M’s native integration on DNAnexus enables teams to to achieve faster, de-risked hit-to-lead & build more predictive AI.

Streamline your analysis of the Tahoe-100M single-cell dataset to accelerate drug discovery and enable better patient stratification outcomes. https://t.co/ir21XaDoVb #SingleCell #DrugDiscovery #AI #Biomarkers #PopulationHealth #PrecisionMedicine

Accelerate your population-scale research using our suite of intuitive and robust cohort analytics tools. Request a demo today: https://t.co/sB7L1XHYPg #PopulationHealth #Genomics #Multiomics #SomaticVariants #GeneExpression #CohortAnalytics

Break free from data silos with the DNAnexus Platform. Our centralized hub allows you to harmonize your multi-assay data for deeper somatic variant & gene expression insights. Interrogate complex multiomics data within a unified interface.

@uk_biobank If you’re attending in person, make time to meet with our expert team. They can guide you with best practices for analyzing the extensive new UK Biobank data release and generally getting the most out of UKB-RAP! #UKBiobank #PopulationHealth #PrecisionMedicine

We’re excited to join our partners @uk_biobank at their upcoming conference in December! Jeff Keller, DNAnexus Executive VP and General Manager of Health Systems and Biobanks, will be participating in a panel discussion on the UKB-RAP to close the event. https://t.co/epiGuKBtp3

Thank you to the ICH working groups, ISPE, and the PRISM-CRYPTx teams and contributors for trailblazing with us! Learn more about our work to transform global regulatory collaboration:

As early adopters of the ICH standards through the PRISM-CRYPTx collaboration, DNAnexus, @Boehringer & other industry partners have demonstrated that this shift toward structured, modular, and digitally interoperable quality information is no longer theoretical—it is here.

Congratulations to the ICH M4Q(R2) and ICH M11 working groups for delivering harmonized standards! These guidelines move the regulatory ecosystem and all of its stakeholders into a truly digital, structured, and interoperable product and protocol data submission paradigm.

@uk_biobank This significant release includes data from the world’s largest metabolomic study, imaging data from the largest study of its kind, WGS phased data VCF files for all 500,000 participants, and more. Approved researchers can now access all of this data on the UKB-RAP.

New @uk_biobank now available on UKB-RAP! What discoveries will you make with this next tranche of data? https://t.co/zCup2a4iVl #UKBiobank #Genomics #Metabolomics #Imaging #ImagingData #PopulationHealth

Our next webinar will cover strategies for leveraging the single-cell resolution data to reveal gene–drug and gene–gene effects missed by standard screens, biomarker discovery, and training models with unparalleled signal density.